东部和南部非洲的HIV和TB:行为变化和ART影响的证据
HIV and TB in Eastern and Southern Africa: Evidence for behaviour change and the impact of ART
摘要:
联合国艾滋病毒/艾滋病联合规划署(艾滋病规划署)制定了一项目标,确保到2015年全世界1 500万艾滋病毒抗体阳性者接受抗逆转录病毒综合治疗。这一目标很可能实现,需要为2020年和2030年制定新的目标。东部和南部非洲约占世界艾滋病毒感染者总数的一半,为该地区制定可实现和负担得起的目标尤为重要。为了对艾滋病毒和结核病的流行率、发病率和死亡率作出未来预测,并假设抗逆转录病毒疗法的推广和覆盖面处于不同水平,首先必须评估这一流行病的现状。在此,我们回顾了有关艾滋病毒流行率、抗逆转录病毒治疗覆盖率和结核病报告率的国家数据,为未来的预测提供坚实的基础。我们使用这些数据来评估行为改变和抗逆转录病毒疗法在多大程度上减少了艾滋病毒感染者的数量。
英文摘要:
The United Nations Joint Programme on HIV/AIDS (UNAIDS) has set a target to ensure that 15 million HIV-positive people in the world would be receiving combination anti-retroviral treatment (ART) by 2015. This target is likely to be reached and new targets for 2020 and 2030 are needed. Eastern and Southern Africa (ESA) account for approximately half of all people living with HIV in the world and it will be especially important to set reachable and affordable targets for this region. In order to make future projections of HIV and TB prevalence, incidence and mortality assuming different levels of ART scale-up and coverage, it is first necessary to assess the current state of the epidemic. Here we review national data on the prevalence of HIV, the coverage of ART and the notification rates of TB to provide a firm basis for making future projections. We use the data to assess the extent to which behaviour change and ART have reduced the number of people living with HIV who remain infectious.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。